Not throwing away my shot. I am sorry folks...nothing of

New Post Public Reply Private Reply Replies (12) Message Board
jconst345 Goosebumps #83959
1,295
Not throwing away my shot.

I am sorry folks...nothing of substance to post here...except for how I felt about yesterday's call.

It was BY FAR the best call I've personally heard them conduct (in the past ~10 months).

They sounded the most optimistic, the most buttoned up & professional, the least speculative, and talked about the most optionality going forward. Btw, loved Arian (lawyer) setting the record straight on multiple questions, here here!

-EUA on the table, here & in multiple countries
-CD16 - Slam dunk trial will take care of the above if not granted sooner
-CD17 - could be an added subgroup for EUA, but will also pay dividends re: IV knowledge gained for both Covid & all future trials
-HIV receptor occupancy concerns addressed, underway, will be resolved, BLA filed summer, PDUFA at end of year/early 2022
-FDA is friend, not fiend (Mahboob & Nader's comments were both adamant & very reassuring to me)
-Pharma trial partnerships (no no no, please, let me pay the check) on the table
-Samsung revving their engines on our behalf w/ millions of vials of potential as needed
-100% receptor occupancy...wow
-World is aware of CYDY - as far south as Brazil, as far east as Hungary in Europe & Philippines in APAC
-Nader the bulldog has stamp of approval from board
-"Real" lawsuits are behind us, the others are fake news
-Long haulers anecdotes seem positive
-Cancer anecdotes seem positive
-And we all know anecdotes don't come off life support
-Cancer + all future trials/indications are so mind boggling it's hard to wrap my tiny brain around the potential...they are, in some cases, providing clemency for a death sentence. Imagine you are told you will die in 4-6 months, yet you are alive 12 months+, think about that... you don't get to play this game twice... what's that worth to you?

I absolutely love market inefficiencies, LOVE IT. I can buy 2-3x as much for the same $1 here as I could at $4.50 or $6.75. Literally doubling or tripling my eventual payout. Never thought I'd have the chance to add down at these prices, never. I'll take it as a win for me personally.

Kelly:
-'tumor microenvironment is loaded with ccr5'
-'future of Cytodyn is oncology'
-'Covid critical pales in comparison to opportunity in long haulers, long haulers absolutely pales in comparison to oncology'

How Mulholland doesn't jump off a cliff after answering yet another uplist question is beyond me. Torturous.

A few quick Buffett quotes, because he's the oracle for good reason:
"Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble."

"Risk comes from not knowing what you're doing."

"You are neither right nor wrong because the crowd disagrees with you. You are right because your data and reasoning are right."

"Buy into a company because you want to own it, not because you want the stock to go up."
-->I actually feel unbelievably proud AND comfortable sitting on these shares. I am literally entrusting this team to my hard earned cash, I have no problem with that. This team are positive, focused, devoted, and sincere. I have no issue putting faith in them to do the right thing with my $$.

And my personal fav:
"The stock market is a device for transferring money from the impatient to the patient."

So, yes I'm CGiddy and have plenty of Goosebumps. I'll sit & meditate, as my techGURU has taught me, and say my "Ohm's" while waiting patiently for the long term story to play out. In the meantime I'll watch "If you believe in it, they will come" - BorelFields of Dreams. And to all the shorts out there, I'll soon misiu very much...as a HHIGambler, you gotta know when to fold em. Feeling smurphy about things as I can see Zaius on Mt. Olympus getting ready with his LLightning bolt, don't blink or you'll miss it. Float like a butterfly, calstang like a bee. You KenChowder down on that! Shout outs to all those I've missed, the good ones know who you are. ExCYDYng times ahead for Penicillin 2.0. Ali G signing off - Respert!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 8

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 9

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 6

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 21

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 11

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 13

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 13

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 9

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 10

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 10

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Healthcare: AANA's Strong Support for Nursing Act

Updated Category News Views 219

AANA's Commitment to the Nursing Workforce AANA proudly announces its support for the introduction of the Title VIII Nursing Workforce Reauthorization Act. This pivotal piece of legislation aims to secure funding essential for nurses, nursing programs, faculty, and students across the nation. With the ongoing challenge of a nursing shortage and the demand for healthcare...

Continue Reading
Context Therapeutics Welcomes Dr. Smith and Dr. Walker to Board

Updated Category News Views 194

Context Therapeutics Strengthens Leadership Team with New Appointments PHILADELPHIA – Context Therapeutics Inc. (Nasdaq: CNTX), an innovative biopharmaceutical company dedicated to advancing treatments for solid tumors, has announced the addition of two distinguished professionals to its Board of Directors: Dr. Karen Smith and Dr. Luke Walker. Their extensive...

Continue Reading
BetWhale Leads the Charge in 2025's Bitcoin Casino Revolution

Updated Category News Views 123

BetWhale: A New Frontier in Bitcoin Gaming As the online gaming industry evolves, BetWhale emerges as a frontrunner in 2025, mastering the synthesis of cryptocurrency transactions with traditional payment methods. This blended approach enhances the gaming experience, attracting a wide audience including players from various backgrounds. The interface is designed for...

Continue Reading
Explore the Five Forces Transforming Enterprises by 2026

Updated Category News Views 160

Five Forces Driving Enterprise Transformation in 2026 Globant has recently published a compelling report that outlines five critical forces set to revolutionize enterprise operations by 2026. As businesses navigate digital transformation, understanding these trends will be key in achieving success in an increasingly competitive landscape. Understanding the Evolution of AI...

Continue Reading
Passenger Information System Market Projects Major Growth by 2028

Updated Category News Views 93

Overview of the Passenger Information System Market The Passenger Information System Market is on a significant growth trajectory, anticipated to expand from an estimated USD 29.3 billion in 2023 to a remarkable USD 52.6 billion by 2028. This growth represents a robust Compound Annual Growth Rate (CAGR) of 12.4%, reflecting a broad shift towards enhanced travel solutions...

Continue Reading